BioCentury Grand Rounds Heads to Houston, Texas, for Its Sixth Meeting Designed to Connect Early-Stage Science with Today’s Investors and Executives
BioCentury is pleased to announce that registration is now open for the sixth edition of BioCentury Grand Rounds, taking place April 12–14, 2027, in Houston, Texas. The conference convenes academic innovators, biotech founders, biopharma leaders, and investors to bridge the gap between early-stage science and breakthrough new medicines. Registration, scientific poster nominations, and Presenting Company applications are now open.
BioCentury to Host Grand Rounds in Chicago: Where Translational Science Meets Investors and Dealmakers
Top decision-makers from across the biopharma ecosystem will convene in Chicago for the 2nd BioCentury Grand Rounds – U.S., at the intersection of research, investment and drug development. Designed to drive practical progress in R&D, the conference connects academic innovators with biopharma executives and early-stage investors who are building the next wave of biotech breakthroughs.
The 11th BioCentury-BayHelix China Healthcare Summit: Reinvent Your Global Drug Development Strategy in Shanghai
In today’s complex geopolitical climate, global drug development faces unprecedented challenges. Biopharma leaders and investors must rethink their strategies for pipeline development and partnerships.
BioCentury to Host Grand Rounds in Nashville: A Premier Gathering of Drug Development Thought Leaders at the Interface of Academia and Industry
Thought leaders from academia, industry and venture capital will join the launch of BioCentury Grand Rounds next month – a conference that brings biopharma R&D decision-makers, academic innovators and early-stage investors together to discuss critical bottlenecks in the translation of scientific discoveries into the next wave of biotech breakthroughs.
